FTC Chair, Commissioners Issue Joint Statement on Amgen, Horizon Therapeutics
September 02, 2023
September 02, 2023
WASHINGTON, Sept. 2 -- The Federal Trade Commission issued the following statement on Sept. 1, 2023, by Chairwoman Lina M. Khan on the matters of Amgen Inc. and Horizon Therapeutics (File No. 231-0037). The statement was joined by Commissioners Rebecca Kelly Slaughter and Alvaro Bedoya:
* * *
All too often, Americans can't afford the medicines they need. Drug prices in America are higher than they are anywhere else in the world. At the Federal Trade Commission, we . . .
* * *
All too often, Americans can't afford the medicines they need. Drug prices in America are higher than they are anywhere else in the world. At the Federal Trade Commission, we . . .